Cancer stem cell transcriptome landscape reveals biomarkers driving breast carcinoma heterogeneity.
Zhifa ZhangXiao ChenJianying ZhangKostya Ken OstrikovPublished in: Breast cancer research and treatment (2021)
Our study contributes in identifying a CSC feature panel for breast carcinomas that drives breast carcinoma heterogeneity at the transcriptional level, which provides a reservoir for diagnostic marker and/or therapeutic target identification once experimentally validated as demonstrated by ATP6V1B1.